Australia just approved the first new Alzheimer’s treatment in decades. But before patients get their hopes up, there’s a ...

Advisers are of course well placed to help people living with dementia and their families navigate a wide range of issues ...

EXCLUSIVE: Chris Snell is urging anyone who notices these symptoms in a loved one to help them get checked for dementia.

Eli Lilly (NYSE:LLY) has received regulatory approval to market its Alzheimer’s therapy Kisunla (donanemab) in Australia, ...

Alzheimer’s researcher Donald Weaver tells The Conversation Weekly podcast what he’s learnt during more than 30 years of studying the disease.

Sanofi’s 11 months watching over Vigil Neuroscience have led to a $470 million buyout. | Sanofi’s 11 months watching over ...

Alzheimer’s is a complex disease caused by many interacting factors. It’s possible the herpes virus could play a small role – ...

New US dementia cases decreased between 2015 and 2021, but the number of people living with the disease continued to increase.

Dementia rates are rising in China 50% faster than in the rest of the world, according to a new report released as the ...

Sanofi said it entered an agreement to acquire Vigil Neuroscience for approximately $470 million, a deal that adds a new investigational treatment for Alzheimer's disease to the French pharmaceutical ...

The first Alzheimer's blood test cleared by the Food And Drug Administration is poised to change the way doctors diagnose and ...

At least 22 viruses have been tied to Alzheimer's, dementia, or other neurodegenerative diseases, and some researchers have ...